GTM, Biopharma

About TriomicsTriomics is building the AI infrastructure for modern oncology. Across the U.S., cancer care providers rely on highly trained staff to manually review unstructured patient records such as pathology reports, clinical notes, genomic panels, and scanned faxes to support workflows like matching patients to the right clinical trials, preparing for upcoming visits, and quality reporting. We replace that manual effort with task-driven AI agents embedded directly into clinical workflows, automatically processing medical records at scale and in real time.

Make sure to apply quickly in order to maximise your chances of being considered for an interview Read the complete job description below.
Our platform is trusted by 4 of the top 10 Best Hospitals for Cancer ranked by U.S. News, along with several of the largest community oncology practices. We have grown 10x over the last year and now process millions of oncology medical documents each month.
The RoleWe're making our first commercial hire focused on biopharma. This is a build role. You will map a brand-new market, define how Triomics sells into life sciences, and stand up a commercial motion that doesn't exist yet, distinct from our cancer center site deals.
Triomics builds oncology AI for the country's leading cancer centers. Our fully EMR-integrated platform turns dense patient charts into structured clinical data and matches patients to trials. We recently closed a Series B and are scaling from a handful to 25+ enterprise logos. Biopharma is a major part of where we grow next, and right now it's a blank sheet.
The best person for this role comes from a top consulting background, has spent time in or around pharma or health tech, and can hold a credible, strategic conversation with life sciences buyers about how oncology AI changes their work. You'll own the strategy first. You'll also carry it through to the sale, with a compensation structure built to reward what you close.
What You'll DoBuild the biopharma motion from zeroMap the biopharma and life sciences market: where we fit, what to sell, who to sell it toDefine the strategy for landing our first accounts, then the repeatable motion behind itRun the full cycle once you've built it: prospecting, discovery, demos with our team, proposal, and closeLand a first use case, then grow it across the accountBe strategic and credible with life sciences buyersTranslate what our oncology AI does into the language of clinical development, real-world data, and trial operationsBuild relationships across the buying group: clinical, data, operations, and procurementBring a consultative, structured approach to complex, multi-stakeholder dealsOwn the sale, not just the strategyCarry the deals you build through to closed and expandedKeep a clean, current pipeline and forecastThis is where the variable side of your comp lives: you're incented on actually closingBe a force multiplier across the companyFeed the market back into Product: what biopharma needs, what's landing, what's missingPartner with the team on deal strategy and account planningCoordinate with the cancer center side of the business on shared accounts
What Success Looks Like (First 90 Days)You've mapped the biopharma market and have a clear view of your top targetsYou have a qualified pipeline built and a point of view on what we sell and to whomYou've translated the product into a biopharma value story that resonates in discovery callsYou're running deals independently with clean forecastingYou've xzbcwsv closed or meaningfully advanced at least one land opportunityLeadership trusts you to own the function and represent Triomics to sophisticated buyers
Must-haves2+ years at a top management consulting firm (MBB or similar), then roughly 1 year selling into pharma or a comparable health-tech settingStrong consultative selling instincts: you can run a structured, multi-stakeholder enterprise dealCredibility with sophisticated buyers: you can hold a strategic conversation about clinical development or dataHigh initiative and comfort building a function from zero, with no existing playbook to lean onExcellent communication and executive presenceComfortable being an early, quota-carrying seller reporting directly into executive leadership
Nice-to-havesDirect experience selling into biopharma or life sciencesFamiliarity with oncology, clinical trials, or real-world dataExperience at an early-stage startup building a new GTM motionExposure to land-and-expand or enterprise expansion sellingA network across pharma clinical, data, or operations teams